1397 – mpMRI prostate diagnostic scans

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status Complete
  • Type New application
  • Pre-PASC consultation -
  • Pre-MSAC consultation -
  • Outcome -

Application details

Reason for application

New MBS item.

Service or technology in this application

The radiological procedure of multiparametric MRI of the prostate. This consists of a standardized image acquisition protocol involving T2 weighted imaging, Diffusion Weighted Imaging, and Dynamic Contrast Enhancement. It is interpreted using a standardized reporting system, the most common of which is PIRADS.

Type: Investigative

Medical condition this application addresses

In patients with a raised or concerning PSA and under clinical suspicion for prostate cancer, sent by the GP to a specialist Urologist, imaging the prostate with mpMRI before biopsy has major patient benefits, increases patient QALY’s, and is cheaper than the current diagnostic pathway. The number of men that need any biopsy at all by about 50%.The number of men diagnosed with low risk cancer reduces by about 90%, preventing overtreatment and the MRI and targeted biopsy pathway is more accurate than random TRUS biopsies and also gives a better grading of the patient’s particular tumour and uses 90% less needles.

Meetings to consider this application

  • PASC meeting: 
    • 16 April 2015
    • 13 - 14 August 2015
  • ESC meeting: 7 - 8 February 2017
  • MSAC meeting: 
    • 6 - 7 April 2017
    • 27 July 2017
    • 12 December 2017